London, UK

Cell therapy continues to transform the oncology field with advances across in vivo engineering and novel armouring enhancements, but this year has also seen the translation of cell therapies’ curative potential into the autoimmune space to capitalize on their targeting abilities.  Despite investment challenges, innovation is showing no signs of slowing for those working in CAR-T and TCR drug development, as the mission to engineer a disease-free world remains front of mind.  

Providing your team with exclusive access to the most cutting-edge advances across pre-clinical platforms, clinical advances, and streamlined manufacturing, the 7th CAR-TCR Summit Europe is your must-attend forum to stay at the forefront of cell therapy innovations.  

300+ industry experts will unite in London this February 27-29 to brainstorm everything from enhancing target discovery, optimizing durability of response and identifying biomarkers to support recruitment, through to automating production and accelerating analytical processes to reduce operational costs and turnaround times.  

More information